Search all trials

Find therapies in clinical trials near you – page 27

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Endometrial cancer

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Oesophageal adenocarcinoma

Not recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Sacituzumab Govitecan

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Leiomyosarcoma metastatic

Not recruiting

Registered drugNo placebo

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Filgrastim

Contact Research Centre

Essential thrombocythaemia+1

Not recruiting

Registered drugNo placebo

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ropeginterferon Alfa-2B

Contact Research Centre

Bladder transitional cell carcinoma+2

Not recruiting

Registered drugNo placebo

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drug

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Myelodysplastic syndrome

Not recruiting

Registered drug

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Sunitinib

Contact Research Centre

Systemic mastocytosis

Not recruiting

Investigational

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide

Contact Research Centre

Find therapies in clinical trials near you – page 27

352 trials match your criteria

Endometrial cancer

Study of Pembrolizumab and Lenvatinib for Patients with Advanced or Recurrent Endometrial Cancer

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Oesophageal adenocarcinoma

Study of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer

Non-small cell lung cancer metastatic

Study Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Leiomyosarcoma metastatic

Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma

Essential thrombocythaemia+1

Study on Ropeginterferon Alfa-2b for Patients with Essential Thrombocythemia Intolerant or Refractory to Other Treatments

Bladder transitional cell carcinoma+2

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Neoplasm malignant

Study on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer

Myelodysplastic syndrome

Study on Venetoclax and Azacitidine for Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome

Colorectal cancer metastatic

Study Comparing Relatlimab-Nivolumab Combination with Regorafenib or Trifluridine-Tipiracil for Patients with Advanced Metastatic Colorectal Cancer

Gastrointestinal stromal tumour

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Systemic mastocytosis

Study on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.